Ameritas Investment Partners Inc. cut its stake in shares of Clorox Company (The) (NYSE:CLX) by 2.2% during the first quarter, Holdings Channel reports. The fund owned 6,696 shares of the company’s stock after selling 149 shares during the period. Ameritas Investment Partners Inc.’s holdings in Clorox Company (The) were worth $902,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the stock. State Street Corp raised its stake in Clorox Company (The) by 1.3% in the fourth quarter. State Street Corp now owns 7,481,310 shares of the company’s stock valued at $897,899,000 after buying an additional 92,570 shares during the last quarter. Parnassus Investments CA bought a new stake in Clorox Company (The) during the first quarter valued at about $434,255,000. Ameriprise Financial Inc. raised its stake in Clorox Company (The) by 2.4% in the first quarter. Ameriprise Financial Inc. now owns 1,076,072 shares of the company’s stock valued at $146,932,000 after buying an additional 25,110 shares during the last quarter. Norges Bank bought a new stake in Clorox Company (The) during the fourth quarter valued at about $122,784,000. Finally, Swiss National Bank raised its stake in Clorox Company (The) by 13.8% in the first quarter. Swiss National Bank now owns 915,092 shares of the company’s stock valued at $123,382,000 after buying an additional 110,700 shares during the last quarter. 71.58% of the stock is owned by institutional investors and hedge funds.

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Shares of Clorox Company (CLX) opened at 139.50 on Friday. The company has a market capitalization of $17.97 billion, a price-to-earnings ratio of 27.56 and a beta of 0.41. The company’s 50 day moving average price is $134.35 and its 200-day moving average price is $129.41. Clorox Company has a 52 week low of $111.24 and a 52 week high of $140.55.

Clorox Company (The) (NYSE:CLX) last released its quarterly earnings data on Wednesday, May 3rd. The company reported $1.31 EPS for the quarter, beating analysts’ consensus estimates of $1.30 by $0.01. Clorox Company (The) had a return on equity of 215.99% and a net margin of 11.22%. The firm had revenue of $1.48 billion for the quarter, compared to analysts’ expectations of $1.48 billion. During the same period in the prior year, the firm posted $1.21 earnings per share. The firm’s quarterly revenue was up 3.6% on a year-over-year basis. Analysts anticipate that Clorox Company will post $5.31 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 4th. Investors of record on Wednesday, July 19th will be issued a $0.84 dividend. This is a boost from Clorox Company (The)’s previous quarterly dividend of $0.80. This represents a $3.36 dividend on an annualized basis and a yield of 2.41%. Clorox Company (The)’s dividend payout ratio is currently 63.12%.

ILLEGAL ACTIVITY WARNING: “Ameritas Investment Partners Inc. Sells 149 Shares of Clorox Company (The) (CLX)” was first reported by Watch List News and is the property of of Watch List News. If you are accessing this piece of content on another website, it was stolen and reposted in violation of U.S. & international copyright law. The original version of this piece of content can be viewed at https://www.watchlistnews.com/ameritas-investment-partners-inc-sells-149-shares-of-clorox-company-the-clx/1372041.html.

Several equities research analysts have recently issued reports on CLX shares. Zacks Investment Research raised Clorox Company (The) from a “hold” rating to a “buy” rating and set a $151.00 price objective for the company in a research note on Wednesday, April 5th. Royal Bank Of Canada set a $115.00 price objective on Clorox Company (The) and gave the company a “hold” rating in a research note on Tuesday, March 21st. Vetr raised Clorox Company (The) from a “hold” rating to a “buy” rating and set a $139.67 price objective for the company in a research note on Monday, April 24th. Jefferies Group LLC set a $138.00 price objective on Clorox Company (The) and gave the company a “hold” rating in a research note on Wednesday, May 3rd. Finally, BMO Capital Markets reaffirmed a “buy” rating and issued a $136.00 price objective on shares of Clorox Company (The) in a research note on Thursday, May 4th. Eleven equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $128.97.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with Analyst Ratings Network's FREE daily email newsletter.